TY  - JOUR
T1  - USe of proton pump inhibitors and mortality among institutionalized older people
AU  - Bell J, Strandberg TE, Teramura-Gronblad M, Laurila JV, Tilvis RS, Pitkälä KH
Y1  - 2010/09/27
N1  - 10.1001/archinternmed.2010.304
JO  - Archives of Internal Medicine
SP  - 1604
EP  - 1605
VL  - 170
IS  - 17
N2  - 
Evidence is accumulating in relation to adverse events associated with proton pump inhibitors (PPIs). Reports in the Archives have demonstrated an association with fractures,1Clostridium difficile infections,2 and community-acquired pneumonia.3 Proton pump inhibitors may also attenuate the antiplatelet benefits of clopidogrel.4 Because frail older people often use PPIs and may be especially vulnerable, we investigated the association between PPIs and all-cause mortality in 2 cohorts of institutionalized people.

SN  - 0003-9926
M3  - doi: 10.1001/archinternmed.2010.304
UR  - http://dx.doi.org/10.1001/archinternmed.2010.304
ER  -